GMP-compliant cannabinoid based therapeutic actives

About

Dedicated biotechnology company providing cannabinoid based therapeutic actives
Welcome to GESLabs

Committed to developing safe and high-quality medicines for patients

By harnessing the power of naturally abundant therapies and incorporating modern scientific discoveries, we are at the forefront of unveiling the vast medical and health-related benefits that cannabinoids offer. 

Embark on this journey with us as we lead the way in pioneering research and innovation, establishing ground-breaking benchmarks through the developments of our cannabinoid-based product range.

Our Technology

We take pride in our state-of-the-art active pharmaceutical manufacturing solution, specifically designed and built to standardize our cannabinoid-based therapy applications.

Our technology suite includes GMP active extraction, intermediate API production, and API isolation, providing a full range of manufacturing capabilities.

Our bespoke manufacturing skids are designed to meet the highest global GMP requirements and regulations. By utilizing cryoethanol solutions and inline refinement technologies, we offer end-to-end pant-to-API solutions with maximized outputs and high-quality inputs. Our technologies are engineered for high efficiencies, allowing for cost-effective scalability, thus enabling our customers to achieve their goals.

At our core, we believe that quality is paramount, and we strive to create products that meet the highest standards while delivering optimal patient outcomes.

The Leading Edge

World Class Technology

Pharma Engineering
Team

In-House Research & Development

Global Quality Standards

GMP-Compliant

Why medical cannabis?

Medical cannabis refers to the use of components as a therapy to manage certain ailment-specific conditions and their associated symptoms.

These components of cannabis, specifically CBD and THC have shown to act on the endocannabinoid system within the body and so have been proven to have medicinal properties for certain diseases.

Pharmaceutical preparations of cannabis have been clinically tested and approved for use in the following indications:

  • Lennox-Gastaut syndrome and Dravet Syndrome
  • Spasticity associated with multiple sclerosis
  • Nausea and vomiting associated with chemotherapy
  • Nausea and appetite loss due to chemotherapy, HIV or AIDS

Our Team

At the heart of our company lies a core team of exceptionally talented and experienced professionals.

Founded in 2018 by Peter Nel, we are a group of technically-skilled chemical and process pharmaceutical engineers, analytical chemists, regulatory pharmacists, production pharmacists, packaging/brand specialists, and GMP quality assurance experts who share a common vision of creating world-class medical cannabis API products.  

We are committed to delivering high-quality API cannabinoids and alkaloids with specific dosage formats that meet the needs of patients worldwide. As a technology provider, our initial focus was on research and development, and model development. Today, we have leveraged our strengths to drive innovation in the cannabinoid and alkaloid manufacturing space.

We are driven by a relentless desire to push the boundaries of what is possible. We thrive on tackling the most challenging problems and delivering solutions that exceed expectations. Our commitment to quality and innovation is unmatched, and we are dedicated to creating products that truly make a difference in the lives of patients. Join us on our journey as we continue to break new ground in the world of medical cannabis.

Certifications

GES holds a South African Products Health Regulatory Authority (SAHPRA) manufacturing authorization (License No: 1401.-.2) that authorises us in accordance to Section 22C(1)(b) of the Medicines and Related substances Act, 1965 (Act 101 of 1965) to import, export, manufacture, pack, label and distribute cannabinoid containing products as well as a GMP certificate (26/7/3/31/1/G0053/2023).

We also hold a written confirmation of GMP for export of active substances into the European Union for medicinal products for human use, in accordance with Article 46b(2)(b) of Directive 2001/83/EC.

View GESLabs SAHPRA licence here.

  • Bulk API containing cannabinoids, including Dronabinol extracted from cultivated cannabis.
  • Dronabinol formulated extract
  • THC/CBD formulated extract
  • CBD Isolate
  • Dronabinol syringes
  • THC/CBD cartridges
  • Packaging and labelling of manufactured products
  • Re-labelling or redressing
  • Cartoning or secondary packaging
  • Analytical testing
  • Stability
All cannabinoid containing products, except biomass.

All manufactured products.

SAHPRA GMP Certificate in terms with Section 22C(1)(b) and SAHPRA GMP guidelines.

SAHPRA written confirmation of GMP for APIs for active substances exported into the European union for medicinal products for human use in accordance with Article 46b(2)(b) of Directive 2001/83/EC.

Leave your details below to receive our product catalogue

By submitting your details you agree to receive news and company updates from GESLabs.

CBD Isolate Natural

Parameters
Specification
Formulation
>98% CBD
Appearance
White crystalline powder
Packaging
1kg HDPE container
Storage
Tightly closed, protected from light, 15 - 25° C
Shelf Life
24-months (stability ongoing)
Extraction
Ethanol
Origin
South Africa
Stability Status
Conducted according to ICH stability guidelines
Long term studies up to: 24 months (25°C±2°C, 60% ± 5%RH)
Accelerated studies up to: 6 months (40°C±2°C, 75% ± 5%RH)

Distillate + Strain-Specific Terpenes

Parameters
Specification
Formulation
440mg (0.5ml) or 880mg (1ml) THC distillate + Chemotype terpenes
Appearance
Yellow-gold viscous liquid, solid at room temperature
Packaging
1ml SS316 510-Thread cartridge
0.5ml SS316 510-Thread cartridge
Storage
Tightly closed, protected from light, 15 - 25° C
Shelf Life
18 months (on-going)
Extraction
Cryo-ethanol extraction
Low temperature Decarboxylation to preserve terpenes
Origin
South Africa
Stability Status
Conducted according to ICH stability guidelines
Long term studies up to: 18 months (25°C±2°C, 60% ± 5%RH)
Accelerated studies up to: 6 months (40°C±2°C, 75% ± 5%RH)
Strains
"Day Blend", "Night Blend", UK Cheese, Blueberry Kush, Black Cherry Punch, Royal Gorilla, Karels Haze, Critical Kush, Creamy Kees, White Lemon, Original Blitz, Sour OG Cheese, Mandarin Cookies, Jungle Pie, Slurricane, Gooseberry Pie

Distillate + Botanical Terpenes

Parameters
Specification
Formulation
440mg (0.5ml) or 880mg (1ml) THC distillate + Botanical terpenes and/or Flavours
Appearance
Yellow-gold viscous liquid, solid at room temperature
Packaging
1ml SS316 510-Thread cartridge
0.5ml SS316 510-Thread cartridge
Storage
Tightly closed, protected from light, 15 - 25° C
Shelf Life
18 months (on-going)
Extraction
Cryo-ethanol extraction
Low temperature Decarboxylation to preserve terpenes
Origin
South Africa
Stability Status
Conducted according to ICH stability guidelines
Long term studies up to: 18 months (25°C±2°C, 60% ± 5%RH)
Accelerated studies up to: 6 months (40°C±2°C, 75% ± 5%RH)
Options
Blueberry Haze, Grape, Blue Dream, Orange, GG#4 (Live Resin)

Live Rosin Strain Specific

Parameters
Specification
Formulation
375mg (0.5ml) or 750mg (1ml) THC Live Rosin
Appearance
Yellow-gold viscous liquid, solid at room temperature
Packaging
1ml SS316 510-Thread Cartridge
0.5ml SS316 510-Thread Cartridge
Storage
Tightly closed, protected from light, 15 - 25° C
Shelf Life
18 months (on-going)
Extraction
EP-grade water and low temperature pressing, fresh frozen cannabis flower
Origin
South Africa
Stability Status
Conducted according to ICH stability guidelines
Long term studies up to: 18 months (25°C±2°C, 60% ± 5%RH)
Accelerated studies up to: 6 months (40°C±2°C, 75% ± 5%RH)
Strains
GMO Cookies, Wedding Cake, Guerilla Cookies, Platinum Slurricane, Duraflame, East Coast Sour Diesel, Ice Box, Stawguava, Cheetah Piss, Moonshine Haze

Live Resin Strain Specific

Parameters
Specification
Formulation
440mg (0.5ml) or 880mg (1ml) THC Live Resin
Appearance
Yellow-gold viscous liquid, solid at room temperature
Packaging
1ml All-Ceramic 510-Thread Cartridge
0.5ml All-Ceramic 510-Thread Cartridge
Storage
Tightly closed, protected from light, 15 - 25° C
Shelf Life
18 months (on-going)
Extraction
Low temperature hydrocarbon, fresh frozen cannabis flower
Origin
South Africa
Stability Status
Conducted according to ICH stability guidelines
Long term studies up to: 18 months (25°C±2°C, 60% ± 5%RH)
Accelerated studies up to: 6 months (40°C±2°C, 75% ± 5%RH)
Strains
Sour Tangie, OG Kush, Apes in Space

Full-Spectrum Decarboxylated Crude Oil

Parameters
Specification
Formulation
>70% THC <2% CBD
Appearance
Dark Amber liquid, solid at room temperature
Packaging
Insert Argon purged. Amber glass bottle 50ml, 500ml and 2.5L. Glass Type III Polypropylene (PE) Cap
Storage
Tightly closed, protected from light, 15 - 25° C
Shelf Life
24-months (stability ongoing)
Extraction
Cryo-ethanol extraction
Low temperature Decarboxylation to preserve terpenes
Origin
South Africa
Stability Status
Conducted according to ICH stability guidelines
Long term studies up to: 24 months (25°C±2°C, 60% ± 5%RH)
Accelerated studies up to: 6 months (40°C±2°C, 75% ± 5%RH)
Strains
Black Cherry Punch (Hybrid-Indica), Blueberry Kush (Indica), Critical Kush (Indica), Creamy Kees (Hybrid-Indica), Royal Go- rilla (Hybrid-Sativa), Karel’s Haze (Hybrid-Sativa), Bafokeng Choice-White Lemon (Hybrid-Sativa), UK Cheese (Sativa), Original Blitz (Indica) | *More strains on request

Broad-Spectrum Distillate

Parameters
Specification
Formulation
>88% THC <2% CBD
Appearance
Clear yellow-gold viscous liquid, solid at room temperature
Packaging
Insert Argon purged. Amber glass bottle 50ml, 500ml and 2.5L. Glass Type III Polypropylene (PE) Cap
Storage
Tightly closed, protected from light, 15 - 25° C
Shelf Life
24-months (stability ongoing)
Extraction
Cryo-ethanol extraction
Low temperature Decarboxylation to preserve terpenes
Origin
South Africa
Stability Status
Conducted according to ICH stability guidelines
Long term studies up to: 24 months (25°C±2°C, 60% ± 5%RH)
Accelerated studies up to: 6 months (40°C±2°C, 75% ± 5%RH)
Strains
Black Cherry Punch (Hybrid-Indica), Blueberry Kush (Indica), Critical Kush (Indica), Creamy Kees (Hybrid-Indica), Royal Go- rilla (Hybrid-Sativa), Karel’s Haze (Hybrid-Sativa), Bafokeng Choice-White Lemon (Hybrid-Sativa), UK Cheese (Sativa), Original Blitz (Indica)| More strains on request

Live Rosin

Parameters
Specification
Formulation
>70% THC <2% CBD
Appearance
Viscous semi-solid at room temperature, yellow-gold
Packaging
Insert Argon purged. Amber glass bottle 5ml, 50ml, 250ml. Glass Type III Polypropylene (PE) Cap
Storage
Tightly closed, protected from light, 15 - 25° C
Shelf Life
24-months (stability ongoing)
Extraction
Low temperature EP-grade water, fresh frozen cannabis
Origin
South Africa
Stability Status
Conducted according to ICH stability guidelines
Long term studies up to: 24 months (25°C±2°C, 60% ± 5%RH)
Accelerated studies up to: 6 months (40°C±2°C, 75% ± 5%RH)
Strains
GMO Cookies, Wedding Cake, Guerilla Cookies, Platinum Slurricane, Duraflame, East Coast Sour Diesel, Ice Box, Stawguava, Cheetah Piss, Moonshine Haze

Live Resin

Parameters
Specification
Formulation
> 85% THC <2% THC
Appearance
Yellow-gold, semi-solid at room temperature
Packaging
Insert Argon purged. Amber glass bottle 50ml, 500ml and 2.5L. Glass Type III Polypropylene (PE) Cap
Storage
Tightly closed, protected from light, 15 - 25° C
Shelf Life
24-months (stability ongoing)
Extraction
Low temperature hydrocarbon, fresh frozen cannabis flower
Origin
South Africa
Stability Status
Conducted according to ICH stability guidelines
Long term studies up to: 24 months (25°C±2°C, 60% ± 5%RH)
Accelerated studies up to: 6 months (40°C±2°C, 75% ± 5%RH)
Strains
Sour Tangie, OG Kush, Apes in Space

D9-THC API (95+%) Natural

Parameters
Specification
Formulation
> 95% THC, minors according to pharmaceutical monograph
Product Type
API
Appearance
Clear viscous liquid, solid at room temperature
Packaging
Insert Argon purged. Amber glass bottle 50ml, 500ml and 2.5L. Glass Type III Polypropylene (PE) Cap
Storage
Tightly closed, protected from light, 15 - 25° C
Shelf Life
12-months
Extraction
Solvent extraction
Origin
South Africa
Stability Status
Conducted according to ICH stability guidelines
Long term studies up to: 12 months (25°C±2°C, 60% ± 5%RH)
Accelerated studies up to: 6 months (40°C±2°C, 75% ± 5%RH)

Sativa Strains*

Karels Haze

THC: 30%

Mandarin Cookies

THC: 27%

Original Blitz

THC: 27%

Jungle Pie

THC: 26%

* More available on request

CBD Dominant

100mg/ml CBD <4mg/ml THC – 30ml
Parameters
Specification
Formulation
Full spectrum CBD extract with pharma grade MCT oil
Product Type
MCT oral formulation
Appearance
Clear to amber liquid at room temperature
Packaging
30ml amber dropper bottle with a child-resistant lid and syringe
Storage
Tightly closed, protected from light, 15 - 25° C
Shelf Life
12-months
Extraction
Cryo-ethanol extraction
Origin
South Africa
Stability Status
Conducted according to ICH stability guidelines
Long term studies up to: 24 months (25°C±2°C, 60% ± 5%RH)
Accelerated studies up to: 6 months (40°C±2°C, 75% ± 5%RH)

CBD Dominant

200mg/ml CBD <4mg/ml THC – 30ml
Parameters
Specification
Formulation
Full spectrum CBD extract with pharma grade MCT oil
Product Type
MCT oral formulation
Appearance
Clear to amber liquid at room temperature
Packaging
30ml amber dropper bottle with a child-resistant lid and syringe
Storage
Tightly closed, protected from light, 15 - 25° C
Shelf Life
12-months
Extraction
Cryo-ethanol extraction
Origin
South Africa
Stability Status
Conducted according to ICH stability guidelines
Long term studies up to: 24 months (25°C±2°C, 60% ± 5%RH)
Accelerated studies up to: 6 months (40°C±2°C, 75% ± 5%RH)

CBD Dominant

200mg/ml CBD <ND THC – 30ml

Parameters
Specification
Formulation
CBD isolate with pharma grade MCT oil
Product Type
MCT oral formulation
Appearance
Clear to amber liquid at room temperature
Packaging
30ml amber bottle with glass pipette dropper
Storage
Tightly closed, protected from light, 15 - 25° C
Shelf Life
12-months
Extraction
Cryo-ethanol extraction
Origin
South Africa
Stability Status
Conducted according to ICH stability guidelines
Long term studies up to: 24 months (25°C±2°C, 60% ± 5%RH)
Accelerated studies up to: 6 months (40°C±2°C, 75% ± 5%RH)

Balanced

15mg/ml CBD – 15mg/ml THC – 30ml
Parameters
Specification
Formulation
Full spectrum THC and CBD extract with pharma grade MCT oil
Product Type
Oral MCT formulation
Appearance
Clear to amber liquid at room temperature
Packaging
30ml amber bottle with child-resistant lid and 1ml syringe
Storage
Tightly closed, protected from light, 15 - 25° C
Shelf Life
12-months
Extraction
Cryo-ethanol extraction
Origin
South Africa
Stability Status
Conducted according to ICH stability guidelines
Long term studies up to: 24 months (25°C±2°C, 60% ± 5%RH)
Accelerated studies up to: 6 months (40°C±2°C, 75% ± 5%RH)

Balanced

25mg/ml CBD – 25mg/ml THC – 30ml

Parameters
Specification
Formulation
Full spectrum THC and CBD extract with pharma grade MCT oil
Product Type
Oral MCT formulation
Appearance
Clear to amber liquid at room temperature
Packaging
30ml amber bottle with child-resistant lid and 1ml syringe
Storage
Tightly closed, protected from light, 15 - 25° C
Shelf Life
12-months
Extraction
Cryo-ethanol extraction
Origin
South Africa
Stability Status
Conducted according to ICH stability guidelines
Long term studies up to: 24 months (25°C±2°C, 60% ± 5%RH)
Accelerated studies up to: 6 months (40°C±2°C, 75% ± 5%RH)

THC Dominant

<1mg/ml CBD -15mg/ml THC – 50ml

Parameters
Specification
Formulation
Full spectrum THC extract with pharma grade MCT oil
Product Type
Oral MCT formulation
Appearance
Clear viscous liquid, solid a room temperature
Packaging
50ml amber bottle with child-resistant lid and 1ml syringe
Storage
Tightly closed, protected from light, 15 - 25° C
Shelf Life
12-months
Extraction
Cryo-ethanol extraction
Origin
South Africa
Stability Status
Conducted according to ICH stability guidelines
Long term studies up to: 24 months (25°C±2°C, 60% ± 5%RH)
Accelerated studies up to: 6 months (40°C±2°C, 75% ± 5%RH)

THC Dominant

<1mg/ml CBD – 25mg/ml THC – 30ml
Parameters
Specification
Formulation
> 95% THC, minors according to DAC monograph
Product Type
DAC Dronabinol in oily base, MCT-oil formulated according to NRF 22.8
Appearance
Clear viscous liquid, solid a room temperature
Packaging
Insert Argon purged. Amber glass bottle 50ml, 500ml and 2.5L. Glass Type III Polypropylene (PE) Cap
Storage
Tightly closed, protected from light, 15 - 25° C
Shelf Life
12-months
Extraction
Cryo-ethanol extraction
Chromatography purification
Origin
South Africa
Stability Status
Conducted according to ICH stability guidelines
Long term studies up to: 24 months (25°C±2°C, 60% ± 5%RH)
Accelerated studies up to: 6 months (40°C±2°C, 75% ± 5%RH)

THC Solution 25mg/ml

Parameters
Specification
Product Type
Purified THC in oily base, MCT-Oil
Formulation
25mg/ml THC
Appearance
Clear, almost colourless to slightly yellowish viscous solution
Packaging
50ml, 200ml or 500ml amber glass jar Type III, white CR screw cap, magisterial preparation format with TE cap (PP), 2 x THC strip, reaction tube, sterile pipett
Storage
Tightly closed, protected from light, 15 - 25° C
Shelf Life
Ongoing - expected 12 months
Extraction
Solvent extraction and formulation
Origin
South Africa
Stability Status
Conducted according to ICH stability guidelines
Long term studies up to: 24 months (25°C±2°C, 60% ± 5%RH)
Accelerated studies up to: 6 months (40°C±2°C, 75% ± 5%RH)

Indica Strains*

Critical Kush

THC: 25%

Black Cherry Punch

THC: 25%

Blueberry Kush

THC: 24%

Gooseberry Pie

THC: 22%

Chemdog x UK Cheese

THC: 21%

Bubba OG

THC: 20%

Blueberry Muffin

THC: 20%

* More available on request

Hybrid Strains*

Sour OG Cheese

THC: 27%

Royal Gorilla

THC: 25%

White Lemon

THC: 24%

Blunicorn

THC: 20%

Creamy Kees

THC: 20%

UK Cheese

THC: 20%

Orange Velvet Underground

THC: 20%

* More available on request